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We previously demonstrated a marked upregulation in the bone morphogenic protein (BMP)/growth
differentiation factor (GDF) family member, GDF5, which is capable of promoting brown adipogenesis, in
brown adipose tissue (BAT) of obese mice. In this study, we identiﬁed other GDF family members, besides
GDF5 that are responsive to different obesogenic signals in BAT using inborn and acquired obesity animal
models. In BAT from leptin-deﬁcient ob/ob mice, GDF1 expression was preferentially downregulated,
whereas the expression of several other genes in the BMP/GDF family, including GDF5, was upregulated.
Moreover, in cultured brown adipocytes exposed to tunicamycin and hydrogen peroxide, at concentra-
tions not affecting cellular viability, GDF1 expression was signiﬁcantly downregulated. Recombinant
GDF1 failed to signiﬁcantly alter brown adipogenesis, despite the promoted phosphorylation of Smad1/5/
8 in cultured brown adipocytes, but accelerated Smad1/5/8 phosphorylation with a concomitant increase
in the number of migrating cells during exposure in a manner sensitive to activin-like kinase inhibitors in
macrophagic RAW264.7 cells. Similarly, accelerated migration was observed in murine peritoneal mac-
rophages exposed to GDF1. These results indicate that obesity could lead to predominant downregulation
of GDF1 expression in BAT, which can modulate cellular migration through a mechanism relevant to
activation of the downstream Smad signaling pathway in adjacent macrophages.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Brown adipose tissue (BAT) generates heat through mitochondrial
uncoupling of lipid oxidation, whereas white adipose tissue (WAT)
serves as a storage depot for excess energy [1,2]. Recent studies have
demonstrated that adult humans have substantial amounts of func-
tioning BAT [3–6]. Accordingly, BAT presents a potential therapeutic
target to combat obesity and related metabolic diseases through a
mechanism relevant to accelerated energy expenditure in humans.
Brown fat-like adipocytes, which have been described as brite or
beige cells with a feature expressing uncoupling protein-1 (UCP1),
are sporadically found in WAT, whereas classical brown adipocytes
reside in the interscapular and perirenal regions.B.V. This is an open access article u
n adipose tissue; BMP, bone
MEM, Dulbecco’s modiﬁed
th differentiation factor;
ARγ, peroxisome proliferator-
T, white adipose tissue; WT,
i).
.Several factors are implicated in the development of beige cells
in WAT. Of these, activation of peroxisome proliferator-activated
receptor-γ (PPARγ) facilitates transformation of white adipocytes
into brown adipocytes [7,8], whereas ﬁbroblast growth factor-21
was found to promote the conversion of white adipocytes to
brown adipocytes [9]. Bone morphogenic protein (BMP)-7 accel-
erates brown adipocyte differentiation and thermogenesis [10],
whereas BMP8B increases BAT thermogenesis through both cen-
tral and peripheral mechanisms [11]. In addition to these well-
known endogenous factors, we recently reported the importance
of growth differentiation factor-5 (GDF5), which is a member of
the BMP/GDF family, in brown adipogenesis [12]. In fact, trans-
genic mice overexpressing GDF5 in adipose tissues display in-
creased systemic energy expenditure along with the appearance of
beige cells in subcutaneous WAT [12]. Taken together, these ﬁnd-
ings indicate that particular BMP/GDF family members may be
implicated in the development and maturation of brown adipo-
cytes. Thus, these previous ﬁndings prompted us to comprehen-
sively search for particular BMP/GDF family members responsive
to obesity in BAT using leptin-deﬁcient ob/obmice as well as obese
mice fed with a high fat diet (HFD) in vivo.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Y. Onishi et al. / Biochemistry and Biophysics Reports 5 (2016) 216–223 2172. Materials and methods
2.1. Materials
A brown adipocyte cell line derived from newborn wild-type
(WT) mice was kindly provided by Dr. C.R. Kahn (Joslin Diabetes
Center, Boston, MA, USA) [10]. Macrophagic RAW264.7 cells and
adipocytic 3T3-L1 cells were obtained from ATCC (Manassas, VA,
USA). Myoblastic C2C12 cells were provided by RIKEN (Tsukuba,
Japan). Recombinant mouse GDF1 was purchased from R&D Sys-
tems (Minneapolis, MN, USA). Both LDN193189 and SB431542
were purchased from Wako Pure Chemical Industries, Ltd. (Osaka,
Japan). Anti-glyceraldehyde-3-phosphate dehydrogenase, anti-
phospho Smad1/5/8, anti-phospho Smad2, and anti-phospho Akt
were obtained from Cell Signaling Technology (Danvers, MA, USA).
A Mouse GDF1 enzyme-linked immunosorbent assay (ELISA) Kit
was obtained from Bluegene (Shanghai, China). Thunderbird SYBR
qPCR Mix was supplied by Toyobo Co., Ltd. (Osaka, Japan) and
speciﬁc primers for each gene for PCR were listed in Table 1. Diet-
induced obesity (DIO) rodent puriﬁed diet with 60% energy from
fat was obtained from Japan SLC (Shizuoka, Japan). Other chemi-
cals used in this study were of the highest purity and commer-
cially available.Table 1
List of primers used for qPCR in this study.
Genes Upstream (5'-3')
Acvr1 TGCTAATGATGATGGCTTTCC
Acvrl1 GGGCCTTTTGATGCTGTCG
Acvr1b CCCCCTTGTTGTCCTCCT
Acvr1c GTCTGGCTCACCTGCACAT
Acvr2a GCGTTCGCCGTCTTTCTTATC
Acvr2b ACCCCCAGGTGTACTTCTG
Amh CCACACCTCTCTCCACTGGTA
ap2 GATGCCTTTGTGGGAACCT
Arg1 GAACACGGCAGTGGCTTTAAC
BMP1 TTGTACGCGAGAACATACAGC
BMP2 GGGACCCGCTGTCTTCTAGT
BMP3 ACTCCGTGAGACTGAGCCAA
BMP4 TTCCTGGTAACCGAATGCTGA
BMP5 TTACTTAGGGGTATTGTGGGCT
BMP6 AGAAGCGGGAGATGCAAAAGG
BMP7 ACGGACAGGGCTTCTCCTAC
Bmpr1a AATGCAAGGATTCACCGAAAGCCC
Bmpr1b CCCTCGGCCCAAGATCCTA
Bmpr2 AGCAATCGCCCATCGAGACTTGAA
Cebpa CAAGAACAGCAACGAGTACCG
Cebpb CAAGTTCCGCAGGGTGCT
GDF1 TTCTGCCAGGGCACGTGCG
GDF2 CGCAGCCTTAACCTCAGC
GDF3 ATGCAGCCTTATCAACGGCTT
GDF5 ATCGGACTGTTCAACCTTTCAG
GDF6 TGCACGTGAACTTCAAGGAGCTGGGC
GDF7 GAGGGCGTTTGCGACTTTC
Id1 CGACTACATCAGGGACCTGCA
Inha ATGCACAGGACCTCTGAACC
Inhba GGAGAACGGGTATGTGGAGA
Inhbb CCTGAGTGAATGCACACCAC
Lefty1 TGTGTGTGCTCTTTGCTTCC
Mcp1 TCCCAATGAGTAGGCTGGAG
Nodal CCATGCCTACATCCAGAGCCTGC
Pparg TCAGCTCTGTGGACCTCTCC
Ppargc1a GTCAACAGCAAAAGCCACAA
Prdm16 GACATTCCAATCCCACCAGA
Retnla TCAGCAATCCCATGGCGTATAA
Tgfb1 CTCCCGTGGCTTCTAGTGC
Tgfb2 TCGACATGGATCAGTTTATGCG
Tgfb3 CCTGGCCCTGCTGAACTTG
Tgfbr1 TGTGCACCATCTTCAAAAACA
Tnfa GTAGCCCACGTCGTAGCAAAC
Ucp1 TACCAAGCTGTGCGATGTCCA
36b4 GAGGAATCAGATGAGGATATGGGA2.2. Mice and ELISA
Male WT and ob/ob mice with a C57BL/6 background were
obtained from Japan SLC (Shizuoka, Japan). The study was con-
ducted in accordance with the guidelines of the Japanese Society
for Pharmacology and was approved by the Committee for the
Ethical Use of Experimental Animals of Kanazawa University.
Blood was collected from the heart of mice under anesthesia using
needles and syringe, followed by leaving on ice for 5 min and
subsequent centrifugation at 4 °C for 5 min at 20,000g for collec-
tion of plasma. BAT was removed from animals after decapitation,
followed by rinsing with PBS and subsequent homogenization in
PBS. The suspension was sonicated and then centrifugation at 4 °C
for 5 min at 5000g for collection of supernatant. GDF1 level was
measured by ELISA according to manufacturer’s protocols.
2.3. Culturing of brown adipocytes, white adipocytes and myoblasts,
Oil Red O staining, and determination of cellular viability
Brown pre-adipocyte cell lines were derived from newborn
wild-type (WT) mice [10]. Brown pre-adipocytes were cultured in
a differentiation induction cocktail (20 nM insulin, 1 nM triio-
dothyronine, 0.125 mM indomethacin, 0.5 μM dexamethasone,Downstream (5'-3')
TTCACAGTGGTCCTCGTTCC
TGGCAGAATGGTCTCTTGCAG
GGCCCCATCTGTCTCACA
CAGCTATGGCACAAGTGTCAC
GTTGGTTCTGTCTCTTTCCCAAT
CATGGCCGTAGGGAGGTTTC
GGCACAAAGGTTCAGGGGG
CTGTCGTCTGCGGTGATTT
TGCTTAGCTCTGTCTGCTTTGC
CTGAGTCGGGTCCTTTGGC
TCAACTCAAATTCGCTGAGGAC
CCTGTCATAGAGCCACAGCATA
CCTGAATCTCGGCGACTTTTT
CCGTCTCTCATGGTTCCGTAG
GACAGGGCGTTGTAGAGATCC
ATGGTGGTATCGAGGGTGGAA
ACAGCCATGGAAATGAGCACAACC
CAACAGGCATTCCAGAGTCATC
TTCTGGAGGCATATAGCGCTTGGT
GTCACTCGTCAACTCCAGCAC
CCAAGAAGACGGTGGACAA
GGAGCAGCTGCGTGCATGAG
GTTGGAGGCAGGCGTAGA
AGGCGCTTTCTCTAATCCCAG
GCACTCTTATCAAGGGTTAGGTC
T TCATCAGCGTCTGGATGATGGCGTGGT
CTGCTTGTAGACCACGTTGTT
GAACACATGCCGCCTCGG
GGATGGCCGGAATACATAAG
TGGTCCTGGTTCTGTTAGCC
CGAGTCCAGTTTCGCCTAGT
GGGGATTCTGTCCTTGGTTT
AAGTGCTTGAGGTGGTTGTG
TGGTGTTCCAGGAGGACCCTGCC
ACCCTTGCATCCTTCACAAG
TCTGGGGTCAGAGGAAGAGA
CACCTCTGTATCCGTCAGCA
TCATCAGTATTCACTGGGACCATCA
GCCTTAGTTTGGACAGGATCTG
CCCTGGTACTGTTGTAGATGGA
TTGATGTGGCCGAAGTCCAAC
ACCAAGGCCAGCTGACTG
CTGGCACCACTAGTTGGTTGTC
GCACACAAACATGATGACGTTCC
GAGGAATCAGATGAGGATATGGGA
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in DMEM-based growth medium containing 20 nM insulin and
1 nM triiodothyronine for an additional 7 days in either the pre-
sence or absence of GDF1. Cells were stained with Oil Red O using
standard procedures as described elsewhere [13].
The murine pre-adipocytic cell line 3T3-L1 cells were cultured
with 20 nM insulin, 0.5 mM dexamethasone and 0.5 mM isobutyl
methylxanthine for 2 days and subsequently were cultured with
20 nM insulin alone for an additional 2 days. The murine myo-
blastic cell line C2C12 cells were cultured in DMEM containing 10%
FBS, and were used without myogenic differentiation.
To stimulate hypoxia, cells were cultured in dishes placed in a
jar containing an AnaeroPack™-Anaero Anaerobic Gas Generator
(Thermo Fisher Scientiﬁc, Inc., Waltham, MA, USA) at 37 °C for
12 h, depending on the experimental protocol, according to the
manufacturer’s instructions. The oxygen concentration reached a
level of less than 1% within 1 h [14].
Cultured cells were incubated with 0.5 mg/mL of 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT).
Afterward, 0.04 M HCl in isopropyl alcohol was added to the cul-
tured cells to dissolve the formazan. The dissolved suspension was
assayed using an enzyme-linked immunosorbent assay and the
absorbance at a wavelength of 550 nm was measured using a
microplate reader.
2.4. Culture of macrophages and migration assay
RAW264.7 cells were cultured in DMEM supplemented with
FBS as previously described [15]. For preparation of peritoneal
macrophages, 3 mL of sterile phosphate-buffered saline (PBS) was
injected into the peritoneal cavity of mice and then lavage ﬂuids
were collected and centrifuged at 200g for 5 min. The resultant
pellet was subsequently washed with PBS. The obtained macro-
phages were again centrifuged, suspended in DMEM, seeded on
dishes, and allowed to adhere for 2 h. Floating cells were removed
by washing and adherent cells were used as peritoneal macro-
phages in the experiments.
RAW264.7 cells or peritoneal macrophages were seeded on
8 mm-pore chemotaxis membranes. Medium containing
100 ng/mL of GDF-1 was added to the basolateral side of the
membrane and the cells were allowed to migrate for 16 h. At the
end of the assay, the ﬁlter was removed, ﬁxed in methanol, and
stained with Giemsa stain. The ﬁlters were then placed on glass
slides and the cell pellets corresponding to the upper wells were
wiped off with cotton swabs. The number of cells that migrated to
the basolateral side of the chamber was counted.
2.5. Statistical analysis
Results are all expressed as the mean7standard error of the
mean (SEM) and the statistical signiﬁcance was determined by the
two-tailed and unpaired Students’ t-test or the one-way analysis of
variance (ANOVA) with the Holm/Sidak post-hoc test.3. Results
3.1. GDF1 is preferentially downregulated in BAT of obese mice
In accordance with the upregulation of GDF5 expression [12],
we comprehensively searched for responsive BMP/GDF family
member genes in the BAT of leptin-deﬁcient, 12-week-old, ob/ob
mice as a model of genetic obesity (WT mice 24.270.3 g; ob/ob
mice 53.170.8 g). In addition to GDF5, signiﬁcant upregulation
was observed in the expression levels of transforming growth
factor β1 (Tgfb1), BMP3, and inhibin βB (Inhbb) in interscapular BATof ob/ob mice, whereas among the different BMP/GDF family
members, a signiﬁcant decrease was only observed in GDF1 ex-
pression in BAT of ob/ob mice (Fig. 1A). However, no signiﬁcant
change was found in the expression levels of the other tested
member genes. Although constitutive GDF1 expression was de-
tected in bone, muscle, and WAT, but not in the liver or pancreas,
GDF1 expression was not signiﬁcantly altered in these tissues, but
constitutively expressed in ob/ob mice (Fig. 1B). ELISA results
showed that GDF1 levels in BAT of ob/ob mice were signiﬁcantly
decreased (Fig. 1C). We next examined whether acquired obesity
similarly deteriorates GDF1 expression in BAT as observed in ge-
netically obese mice. Brieﬂy, 8-week-old WT mice were main-
tained with either normal chow (NC) or a HFD for 1 and 2 con-
secutive months as a model of DIO. Body weight was signiﬁcantly
higher in mice fed a HFD than in that of mice fed a NC (Fig. 1D).
The expression of speciﬁc marker genes of both M1 (monocyte
chemoattractant protein-1 (Mcp1) and tumor necrosis factor-α
(Tnfa)) and M2 (arginase 1 (Arg1) and resistin-like molecule-α
(Retnla)) macrophages was markedly increased in BAT of mice fed
a HFD for 2 months (Fig. 1E), while the expression of Ucp1 was
signiﬁcantly increased in BAT of mice fed a HFD for 2 months
(Fig. 1F). As observed in genetically obese ob/ob mice, GDF1 ex-
pression was signiﬁcantly downregulated in BAT of mice fed with
HFD, as compared to mice fed with NC (Fig. 1G). However, the
expression of GDF1 (Fig. 1H) and macrophage markers (Supple-
mental Fig. 1) in BAT of mice fed a HFD was not altered when the
mice were maintained under cold condition for 6 h. Moreover,
GDF1 protein levels were signiﬁcantly lower in BAT of mice fed a
HFD as seen in ob/ob mice (Fig. 1I), along with a trend toward the
lower levels of plasma GDF1 without statistical signiﬁcance
(Fig. 1J).
Next, we investigated whether obesity affects the expression of
BMP/GDF receptors in BAT. In BAT from ob/ob mice, a signiﬁcant
decrease was only seen in the expression of activin A receptor, type
1C (Acvr1c) amongst different relevant genes examined, while HFD
did not induce any signiﬁcant alterations of mRNA expression of
BMP receptors (Supplemental Fig. 2). Accordingly, GDF1 would be
only one endogenous factor commonly down-regulated in BAT
within molecules responsible for the input of extracellular BMP/
GDF signals in both genetic and acquired obese mice.
3.2. GDF1 expression is decreased by various stressors in brown
adipocytes
Because obesity is highly associated with the pathophysiology
of various types of cellular stresses, we next determined whether
GDF1 expression was responsive to different stressors relevant to
hypoxic, endoplasmic reticulum (ER), mitochondrial, and oxidative
stresses in cultured brown adipocytes in vitro. For this purpose, we
ﬁrst determined cellular viability using the MTT assay in brown
adipocytes cultured with various stressors at different concentra-
tions for 12 h and found signiﬁcant inhibition of MTT reducing
activity in brown adipocytes exposed to the ER stressor tunica-
mycin at 0.1–1.0 μg/mL (Fig. 2A), the mitochondrial stressor 2,4-
dintriohenol at 1.0 mg/mL (Fig. 2B), and the oxidative stressor
hydrogen peroxide at 500 μM (Fig. 2C), respectively. However,
MTT reduction was not altered in cells cultured under hypoxic
conditions for 12 h (Fig. 2D). These stressors could cause a plethora
of cellular effect. Accordingly, brown adipocytes were then treated
with tunicamycin at 0.01 μg/mL, 2,4-dintriohenol at 0.1 mg/mL
and hydrogen peroxide at 100 μM, to observe whether these
stressors could alter GDF1 expression without affecting cell viabi-
lity. A signiﬁcant downregulation of GDF1 expression was ob-
served in brown adipocytes exposed to 0.01 μg/mL of tunicamycin
(Fig. 2E) and 100 μM hydrogen peroxide (Fig. 2G), while neither
2,4-dintriohenol (Fig. 2F) nor hypoxia (Fig. 2H) signiﬁcantly
Fig. 1. GDF1 is preferentially down-regulated in BAT of obesity model mice. Tissues were isolated from ob/ob mice at 12 weeks of age, followed by determination of (A, B)
mRNA expression by qPCR and (C) GDF1 levels by ELISA (n¼4–6). *Po0.05, **Po0.01, signiﬁcantly different from each control value obtained in WT mice. Adult male WT
mice at 8 weeks old were fed with either NC or HFD for 2 months, followed by determination of (D) body weight and (E–G) mRNA expression in BAT by qPCR (n¼4).
(H) Adult male mice fed a NC or HFD were maintained in cold condition for 6 h, and subsequent determination of mRNA (n¼4). GDF1 levels in (I) BAT and (J) plasma of HFD-
fed mice (n¼4–8). *Po0.05, **Po0.01, signiﬁcantly different from the value obtained in NC-fed mice.
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Fig. 2. GDF1 expression is down-regulated by ER stress and oxidative stress in brown adipocytes. Brown adipocytes were cultured for 12 h with (A) tunicamycin at 0.01–
1 μg/mL, (B) 2,4-dinitrophenol at 0.01–1 mg/mL and (C) hydrogen peroxide at 10–500 μM, followed by determination of cell viability with MTT assay (n¼4). (D) Brown
adipocytes were cultured under hypoxia for 12 h, followed by MTT assay (n¼4). nPo0.05, nnPo0.01, signiﬁcantly different from each control value obtained in cells cultured
without stressors. Brown adipocytes were cultured for 12 h with (E) tunicamycin at 0.01 μg/mL, (F) 2,4-dinitrophenol at 0.1 mg/mL and (G) hydrogen peroxide at 100 μM,
followed by determination of GDF1 expression with qPCR (n¼4–6). (H) Brown adipocytes were cultured under hypoxia for 12 h, followed by determination of GDF1
expression (n¼4). nnPo0.01, signiﬁcantly different from each control value obtained in cells cultured without stressors. White adipocytic 3T3-L1 cells or myoblastic C2C12
cells were similarly cultured for 12 h with (I) 0.01 μg/mL tunicamycin or (J) 100 μM hydrogen peroxide, followed by determination of GDF1 expression with qPCR (n¼4).
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Fig. 3. GDF1 does not affect brown adipogenesis but stimulates macrophage migration through BMP receptor: (A) brown adipocytes were exposed to 100 ng/mL GDF1 for
different periods indicated, followed by determination of the phosphorylation of downstream mediators such as Smad and Akt. Representative images are shown. Brown
adipocytes were cultured with recombinant GDF1 at 100 ng/mL for 7 days, followed by determination of (B) Oil red O staining, (C and E) mRNA expression by qPCR, and
(D) BRE-luc activity (n¼4). (F) Macrophagic RAW264.7 cells were exposed to 100 ng/mL GDF1 for different periods indicated, followed by determination of the phos-
phorylation of downstream mediators such as Smad and Akt. Representative images are shown. (G) RAW264.7 cells and peritoneal macrophages (PM) were seeded onto
chemotaxis membranes, followed by addition of medium containing 100 ng/mL GDF1 to the basolateral side of the membrane, and subsequent culture for 16 h for de-
termination of the number of macrophages migrated (n¼6). (H) RAW264.7 cells were pre-treated with LDN193189 or SB431542 at 10 μM, followed by culture with
100 ng/mL GDF1 for 16 h and subsequent determination of the number of cells migrated (n¼3–6). nPo0.05, nnPo0.01, signiﬁcantly different from the value obtained from
cells not treated with GDF1. #Po0.05, signiﬁcantly different from the value obtained from cells treated with GDF1 alone.
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Y. Onishi et al. / Biochemistry and Biophysics Reports 5 (2016) 216–223222affected GDF1 expression in brown adipocytes under these ex-
perimental conditions. In contrast to brown adipocytes, neither
tunicamycin (Fig. 2I) nor hydrogen peroxide (Fig. 2J) signiﬁcantly
alter GDF1 expression in either white adipocytic 3T3-L1 cells or
myoblastic C2C12 cells.
3.3. GDF1 did not affect differentiation of brown adipocytes, but
stimulated migration of macrophages
We next investigate whether GDF1 modulates differentiation of
brown adipocytes as observed with GDF5 [16]. Although exposure
to GDF1 facilitated phosphorylation of Smad1/5/8 and Akt
(Fig. 3A), as observed in GDF5-treated brown adipocytes [12],
GDF1 failed to signiﬁcantly affect accumulation of lipid droplets
stained with Oil Red-O (Fig. 3B) or expression proﬁles of several
marker genes, including Ucp1, PPARγ co-activator 1α (Ppargc1a),
PRD1-BF-RIZ1 homologous domain containing protein-16
(Prdm16), Pparg, adipocyte protein 2 (aP2), CCAAT enhancer-
binding protein α (Cebpa), and Cebpb, in cultured brown adipo-
cytes (Fig. 3C). On the contrary, GDF1 signiﬁcantly enhanced the
reporter activity of BRE-luc, a luciferase plasmid with BMP re-
sponsive element (Fig. 3D) and increased the expression of in-
hibitor of differentiation 1 (Id1), a major downstream effector of
BMP signaling (Fig. 3E), indicating that GDF1 indeed could turn on
BMP/Smad signal transduction in brown adipocytes.
Macrophage inﬁltration into adipose tissues has been well
documented in obese mice and humans [17,18], whereas parti-
cular BMP/GDF family members were shown to be responsible for
migration of macrophages rather than modulation of adipocyte
differentiation [19]. Thus, we next investigated whether GDF1 af-
fects migration of macrophages in vitro and found that exposure to
GDF1 led to marked phosphorylation of both Smad1/5/8 and Akt
in macrophagic RAW264.7 cells (Fig. 3F), similar to that in brown
adipocytes (Fig. 3A). A signiﬁcant increase in the number of mi-
grated cells was observed with RAW264.7 cells and peritoneal
macrophages after culturing with GDF1 (Fig. 3G). LDN193189, an
inhibitor of activin-like kinase 2/3 (ALK2/3), almost completely
inhibited the migration of cells increased by GDF1, whereas
SB431542, an inhibitor of ALK4/5/7, failed to signiﬁcantly inhibit
the GDF1-induced increase in the number of migrating cells at the
concentration used (Fig. 3H). The treatment of LDN193189 or
SB431542 alone did affect the number of migrating cells (Fig. 3H).
These results indicate that GDF1 promotes macrophage migration
through the activation of the receptor complex between BMP
type-I receptor composed of ALK2 or ALK3 and BMP type-II re-
ceptor in macrophages.4. Discussion
In this study, we identiﬁed GDF1 as an endogenous factor
downregulated in BAT of both genetic and acquired obesity mice.
The current ﬁndings that GDF1 promoted macrophage migration
without affecting brown adipogenesis in vitro, and GDF1 protein
level was signiﬁcantly decreased in BAT but not in circulation of
obese mice in vivo, gave rise to the notion that GDF1 is usually
secreted from brown adipocytes to promote macrophage inﬁltra-
tion into BAT in vivo as a paracrine factor instead of endocrine
factor. Taking into consideration the prevailing view that obesity
induces marked macrophage inﬁltration into adipose tissues
[17,18], it is conceivable that downregulation of GDF1 expression
could lead to a feedback compensation to counteract extra-
ordinarily excessive inﬁltration of adjacent macrophages into BAT
in an obesogenic situation, as shown in Supplemental Fig. 3. Future
analyses using conditional knockout mice defective of GDF1 from
BAT will undoubtedly help to further elucidate the physiologicaland pathological roles of this particular BMP/GDF family member
expressed by macrophage inﬁltrating brown adipocytes during
obesity in vivo. The differential sensitivities to ALK inhibitors are
suggestive of an idea that extracellular GDF1 promotes macro-
phage migration through activation of the receptor complex be-
tween BMP type-I receptor composed of ALK2 or ALK3 and BMP
type-II receptor in macrophages.
It should be emphasized that GDF1 failed to affect cell vitality
and differentiation in brown adipocytes in spite of increased
Smad1/5/8 phosphorylation, which is required for promotion by
GDF5 of brown adipogenesis [20]. In addition to activation of the
Smad pathway, BMP/GDF family members are shown to utilize
various intracellular signaling pathways to transduce their signals
essential for regulation of a variety of biological activities [21,22].
BMP7 accelerated a full program of brown adipogenesis through
activation of p38 mitogen-activated protein kinase (MAPK) [10],
for example, while BMP8B centrally or peripherally enhanced BAT
thermogenesis along with activation of either AMP-activated
protein kinase (AMPK) or p38 MAPK [11]. The phosphatidylinositol
3-kinase (PI3K)/Akt pathway is also involved in GDF5-induced
brown adipogenesis [16]. Accordingly, BMP/GDF family would
sophisticatedly regulate brown adipogenesis through activation of
various intracellular signaling pathways including Smad1/5/8,
PI3K/Akt, p38 MAPK and AMPK. Although the exact reason why
GDF1 failed to promote brown adipogenesis despite activation of
the Smad pathway is not clariﬁed so far, the paradoxical property
between GDF1 and GDF5 on brown adipogenesis could be at least
in part accounted for by taking into consideration the complex
signal crosstalk among a variety of intracellular pathways in
brown adipocytes.
The reason why GDF1 expression was downregulated in brown
adipocytes exposed to ER stress and hydrogen peroxide in vitro, as
well as in BAT of inborn and acquired obesity mice in vivo, has not
yet been clariﬁed. The Smad2/3 pathway reportedly plays a role in
mechanisms underlying TGF-β1-mediated downregulation of
GDF1 expression in peripheral blood mononuclear cells [23]. The
ER stressor tunicamycin induced Smad2/3 phosphorylation in al-
veolar epithelial cells [24], whereas oxidative stress indirectly
promoted Smad2 phosphorylation in myoﬁbroblasts [25]. These
previous ﬁndings indicate that activation of the Smad2/3 signaling
pathway would be at least in part responsible for the predominant
downregulation of GDF1 expression in brown adipocytes in re-
sponse to obesogenic signals amongst a variety of BMP/GDF family
members in a particular situation. In silico analysis of the upstream
promoter regions of GDF1 along with reporter plasmid assays will
be undoubtedly beneﬁcial for further clariﬁcation in future studies.
It is conceivable that a repressor type of a particular nuclear
transcription factor would be upregulated to participate in the
predominant downregulation of GDF1 in brown adipocytes under
obesity.
Although evidence is accumulating for macrophage inﬁltration
into WAT in obesity and relevant diabetes mellitus, little attention
has been paid to the possible importance of macrophages in the
physiology and pathophysiology of BAT during obesity. However,
macrophages have been recently shown to be essential for heat
production and adaptive thermogenesis by producing noradrena-
line in BAT [26]. Moreover, macrophages may contribute to the
development of functional beige cells in subcutaneous WAT [27].
The present ﬁndings that genetic and acquired obesity similarly
downregulated expression of GDF1, which is capable of accel-
erating macrophage migration in BAT rather than WAT, led us to
speculate that the number of inﬁltrating macrophages would be
reduced in BAT through a mechanism associated with GDF1
downregulation toward decreased energy expenditure by brown
adipocytes during obesity. Future analysis of macrophage inﬁltra-
tion into BAT of obese animals in vivo, as well as identiﬁcation of
Y. Onishi et al. / Biochemistry and Biophysics Reports 5 (2016) 216–223 223the type of macrophages inﬁltrated, will undoubtedly aid in de-
termining a solution to this concern. Pharmacological manipula-
tions of the GDF1/BMP receptor pathway in macrophages as well
as GDF1 secretion from brown adipocytes presents a plausible
approach for the discovery and development of novel strategies to
combat obesity and related metabolic diseases in human beings.Conﬂict of interest
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